(Q39365743)

11 September 2017

title

Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells (English)

1 reference

11 September 2017

1 reference

Tatiana M Tilli

1

1 reference

11 September 2017

Kivvi D Mello

2

1 reference

11 September 2017

Luciana B Ferreira

3

1 reference

11 September 2017

Aline R Matos

4

1 reference

11 September 2017

Maria Thereza S Accioly

5

1 reference

11 September 2017

Paulo A S Faria

6

1 reference

11 September 2017

Akeila Bellahcène

7

1 reference

11 September 2017

Vincent Castronovo

8

1 reference

11 September 2017

Etel R Gimba

9

1 reference

11 September 2017

publication date

11 April 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

72

1 reference

11 September 2017

issue

15

1 reference

11 September 2017

page(s)

1688-1699

1 reference

Pre- and post-translational regulation of osteopontin in cancer

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

Osteopontin: role in cell signaling and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

Osteopontin: an effector and an effect of tumor metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

Regulation of Erk1/2 activation by osteopontin in PC3 human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

Osteopontin-c splicing isoform contributes to ovarian cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

An osteopontin splice variant induces anchorage independence in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

Modulation of RNA splicing as a potential treatment for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

Tenascin-C regulates proliferation and migration of cultured astrocytes in a scratch wound assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

Cell motility and spreading are suppressed by HOXA4 in ovarian cancer cells: possible involvement of beta1 integrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

Minireview: regulation of prostatic stem cells by stromal niche in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

Mesenchymal stem cells require integrin β1 for directed migration induced by osteopontin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

Cancer biomarkers: knowing the present and predicting the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

Present and future of PI3K pathway inhibition in cancer: perspectives and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

CRBP suppresses breast cancer cell survival and anchorage-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22523

21 January 2018

Identifiers

DOI

10.1002/PROS.22523

1 reference

release_rkjfaqrfaje3ji7rogfpfkmmgy

11 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rkjfaqrfaje3ji7rogfpfkmmgy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference